Literature DB >> 12717449

Telomerase modulates expression of growth-controlling genes and enhances cell proliferation.

Laura L Smith1, Hilary A Coller, James M Roberts.   

Abstract

Most somatic cells do not express sufficient amounts of telomerase to maintain a constant telomere length during cycles of chromosome replication. Consequently, there is a limit to the number of doublings somatic cells can undergo before telomere shortening triggers an irreversible state of cellular senescence. Ectopic expression of telomerase overcomes this limitation, and in conjunction with specific oncogenes can transform cells to a tumorigenic phenotype. However, recent studies have questioned whether the stabilization of chromosome ends entirely explains the ability of telomerase to promote tumorigenesis and have resulted in the hypothesis that telomerase has a second function that also supports cell division. Here we show that ectopic expression of telomerase in human mammary epithelial cells (HMECs) results in a diminished requirement for exogenous mitogens and that this correlates with telomerase-dependent induction of genes that promote cell growth. Furthermore, we show that inhibiting expression of one of these genes, the epidermal growth factor receptor (EGFR), reverses the enhanced proliferation caused by telomerase. We conclude that telomerase may affect proliferation of epithelial cells not only by stabilizing telomeres, but also by affecting the expression of growth-promoting genes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12717449     DOI: 10.1038/ncb985

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  154 in total

1.  Coexpression analysis of human genes across many microarray data sets.

Authors:  Homin K Lee; Amy K Hsu; Jon Sajdak; Jie Qin; Paul Pavlidis
Journal:  Genome Res       Date:  2004-06       Impact factor: 9.043

Review 2.  In search of "stemness".

Authors:  Jingli Cai; Mark L Weiss; Mahendra S Rao
Journal:  Exp Hematol       Date:  2004-07       Impact factor: 3.084

3.  Small-molecule-based identification of dynamic assembly of E2F-pocket protein-histone deacetylase complex for telomerase regulation in human cells.

Authors:  Jaejoon Won; Seungwoo Chang; Sangtaek Oh; Tae Kook Kim
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-19       Impact factor: 11.205

4.  Separation of telomerase functions by reverse genetics.

Authors:  Shibani Mukherjee; Eduardo J Firpo; Yang Wang; James M Roberts
Journal:  Proc Natl Acad Sci U S A       Date:  2011-09-26       Impact factor: 11.205

5.  Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence.

Authors:  Erica K Benson; Sam W Lee; Stuart A Aaronson
Journal:  J Cell Sci       Date:  2010-07-06       Impact factor: 5.285

Review 6.  Biologic function and clinical potential of telomerase and associated proteins in cardiovascular tissue repair and regeneration.

Authors:  Rosalinda Madonna; Raffaele De Caterina; James T Willerson; Yong-Jian Geng
Journal:  Eur Heart J       Date:  2010-12-10       Impact factor: 29.983

Review 7.  The role of telomeres and telomerase reverse transcriptase isoforms in pluripotency induction and maintenance.

Authors:  Jonathan H Teichroeb; Joohwan Kim; Dean H Betts
Journal:  RNA Biol       Date:  2016-01-19       Impact factor: 4.652

8.  No attenuation of the ATM-dependent DNA damage response in murine telomerase-deficient cells.

Authors:  Natalie Erdmann; Lea A Harrington
Journal:  DNA Repair (Amst)       Date:  2008-12-25

9.  An investigation of the effects of the core protein telomerase reverse transcriptase on Wnt signaling in breast cancer cells.

Authors:  Imke Listerman; Francesca S Gazzaniga; Elizabeth H Blackburn
Journal:  Mol Cell Biol       Date:  2013-11-11       Impact factor: 4.272

10.  Down-regulation of an inhibitor of cell growth, transmembrane protein 34 (TMEM34), in anaplastic thyroid cancer.

Authors:  J Akaishi; M Onda; J Okamoto; S Miyamoto; M Nagahama; K Ito; A Yoshida; K Shimizu
Journal:  J Cancer Res Clin Oncol       Date:  2006-10-28       Impact factor: 4.553

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.